KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Progyny (PGNY) Total Current Liabilities (2018 - 2025)

Historic Total Current Liabilities for Progyny (PGNY) over the last 8 years, with Q3 2025 value amounting to $210.5 million.

  • Progyny's Total Current Liabilities rose 96.99% to $210.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $210.5 million, marking a year-over-year increase of 96.99%. This contributed to the annual value of $168.6 million for FY2024, which is 931.59% down from last year.
  • According to the latest figures from Q3 2025, Progyny's Total Current Liabilities is $210.5 million, which was up 96.99% from $220.4 million recorded in Q2 2025.
  • Over the past 5 years, Progyny's Total Current Liabilities peaked at $237.1 million during Q1 2025, and registered a low of $98.8 million during Q2 2021.
  • Moreover, its 5-year median value for Total Current Liabilities was $186.0 million (2023), whereas its average is $171.0 million.
  • In the last 5 years, Progyny's Total Current Liabilities soared by 7129.95% in 2021 and then tumbled by 931.59% in 2024.
  • Over the past 5 years, Progyny's Total Current Liabilities (Quarter) stood at $98.8 million in 2021, then skyrocketed by 61.43% to $159.5 million in 2022, then grew by 16.56% to $186.0 million in 2023, then decreased by 9.32% to $168.6 million in 2024, then increased by 24.83% to $210.5 million in 2025.
  • Its Total Current Liabilities stands at $210.5 million for Q3 2025, versus $220.4 million for Q2 2025 and $237.1 million for Q1 2025.